Abbott Raises 2026 Profit Forecast Due to Strong Performance in Diagnostics and Heart Devices
Abbott reported better-than-expected quarterly results, driven by strong performance from its cancer diagnostics business and heart devices. The company raised its full-year profit forecast for the first time since acquiring Exact Sciences.
Topics: cancer_testing diagnostics financial_results medical_devices